152 related articles for article (PubMed ID: 31347557)
1. Changing trends of presentation of central nervous system tuberculosis: Relative prevalence of cranial and spinal tuberculosis and drug resistance patterns.
Muralidharan V; Nair BR; Rajshekhar V
Neurol India; 2019; 67(3):792-796. PubMed ID: 31347557
[TBL] [Abstract][Full Text] [Related]
2. Multidrug-resistant tuberculosis of the spine--is it the beginning of the end? A study of twenty-five culture proven multidrug-resistant tuberculosis spine patients.
Pawar UM; Kundnani V; Agashe V; Nene A; Nene A
Spine (Phila Pa 1976); 2009 Oct; 34(22):E806-10. PubMed ID: 19829244
[TBL] [Abstract][Full Text] [Related]
3. Xpert
Kohli M; Schiller I; Dendukuri N; Dheda K; Denkinger CM; Schumacher SG; Steingart KR
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012768. PubMed ID: 30148542
[TBL] [Abstract][Full Text] [Related]
4. Central nervous system and spinal tuberculosis in children at a tertiary care center in Saudi Arabia.
Al Ayed M; Al Jumaah S; AlShail E
Ann Saudi Med; 2013; 33(1):6-9. PubMed ID: 23458932
[TBL] [Abstract][Full Text] [Related]
5. Tuberculosis of the spine in children - does drug resistance affect surgical outcomes?
Pinto D; Dhawale A; Shah I; Rokade S; Shah A; Chaudhary K; Aroojis A; Mehta R; Nene A
Spine J; 2021 Dec; 21(12):1973-1984. PubMed ID: 34116216
[TBL] [Abstract][Full Text] [Related]
6. Changing prevalence and resistance patterns in children with drug-resistant tuberculosis in Mumbai.
Shah I; Shah F
Paediatr Int Child Health; 2017 May; 37(2):135-138. PubMed ID: 27686119
[TBL] [Abstract][Full Text] [Related]
7. Drug sensitivity patterns in Xpert-positive spinal tuberculosis: an observational study of 252 patients.
Upadhyay M; Patel J; Kundnani V; Ruparel S; Patel A
Eur Spine J; 2020 Jul; 29(7):1476-1482. PubMed ID: 32055960
[TBL] [Abstract][Full Text] [Related]
8. Low prevalence of MDR-TB in Lao PDR: results from the first national anti-tuberculosis drug resistance survey.
Iem V; Dean A; Zignol M; Vongvichit P; Inthavong D; Siphanthong S; Sorsavanh T; Kim SJ; Shin S; Sébert J; Chittamany P
Trop Med Int Health; 2019 Apr; 24(4):421-431. PubMed ID: 30663180
[TBL] [Abstract][Full Text] [Related]
9. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
Steingart KR; Schiller I; Horne DJ; Pai M; Boehme CC; Dendukuri N
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009593. PubMed ID: 24448973
[TBL] [Abstract][Full Text] [Related]
10. Drug Resistance in Children with Central Nervous System Tuberculosis from a Tertiary Care Center in Mumbai.
Mane SS; Janardhanan J; Pustake M; Ali MK; Khan GI
J Trop Pediatr; 2021 Dec; 67(6):. PubMed ID: 34918167
[TBL] [Abstract][Full Text] [Related]
11. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
Steingart KR; Sohn H; Schiller I; Kloda LA; Boehme CC; Pai M; Dendukuri N
Cochrane Database Syst Rev; 2013 Jan; (1):CD009593. PubMed ID: 23440842
[TBL] [Abstract][Full Text] [Related]
12. Spinal tuberculosis in non-HIV-infected patients: 10 year experience of a medical center in central Taiwan.
Weng CY; Chi CY; Shih PJ; Ho CM; Lin PC; Chou CH; Wang JH; Ho MW
J Microbiol Immunol Infect; 2010 Dec; 43(6):464-9. PubMed ID: 21195972
[TBL] [Abstract][Full Text] [Related]
13. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
14. Central nervous system tuberculosis.
Dian S; Ganiem AR; van Laarhoven A
Curr Opin Neurol; 2021 Jun; 34(3):396-402. PubMed ID: 33661159
[TBL] [Abstract][Full Text] [Related]
15. Central nervous system tuberculosis.
Cherian A; Thomas SV
Afr Health Sci; 2011 Mar; 11(1):116-27. PubMed ID: 21572867
[TBL] [Abstract][Full Text] [Related]
16. Retrospective Study of 967 Patients With Spinal Tuberculosis.
Shi T; Zhang Z; Dai F; Zhou Q; He Q; Luo F; Hou T; Xu J
Orthopedics; 2016 Sep; 39(5):e838-43. PubMed ID: 27172367
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of multidrug resistance in Mycobacterium tuberculosis isolates from HIV seropositive and seronegative patients with pulmonary tuberculosis in north India.
Sethi S; Mewara A; Dhatwalia SK; Singh H; Yadav R; Singh K; Gupta D; Wanchu A; Sharma M
BMC Infect Dis; 2013 Mar; 13():137. PubMed ID: 23497169
[TBL] [Abstract][Full Text] [Related]
18. Rifampicin mono-resistance in Mycobacterium tuberculosis in KwaZulu-Natal, South Africa: a significant phenomenon in a high prevalence TB-HIV region.
Coovadia YM; Mahomed S; Pillay M; Werner L; Mlisana K
PLoS One; 2013; 8(11):e77712. PubMed ID: 24223122
[TBL] [Abstract][Full Text] [Related]
19. Distribution patterns of drug resistance Mycobacterium tuberculosis among HIV negative and positive tuberculosis patients in Western Kenya.
Ogwang MO; Imbuga M; Ngugi C; Mutharia L; Magoma G; Diero L
BMC Infect Dis; 2021 Nov; 21(1):1175. PubMed ID: 34809602
[TBL] [Abstract][Full Text] [Related]
20. Drug resistance pattern of Mycobacterium tuberculosis in a university hospital in Taiwan, 1998-2002.
Liaw YS; Hsueh PR; Yu CJ; Wang SK; Yang PC; Luh KT
J Formos Med Assoc; 2004 Sep; 103(9):671-7. PubMed ID: 15361939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
